BMJ  2005;331:1474 (17 December), doi:10.1136/bmj.331.7530.1474-b

Letter

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs

COX-2 inhibitors were thought of as a safe option

The first 150 words of the full text of this article appear below.

EDITOR—The study by Hippisley-Cox et al into the safety of cyclo-oxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDS) is subject to more indication bias than they suggest.¹

When the study began, five years ago, COX-2 inhibitors were widely regarded as safer to prescribe in patients at high risk of developing gastrointestinal side effects than NSAIDs,² although there were doubts over their cardiovascular safety.³ Working in general practice at the time, we saw COX-2 inhibitors used in primary care patients who had mild upper gastrointestinal symptoms or history, as a safe option. They were prescribed particularly in elderly people, in whom opiate analgesics often cause significant adverse effects. This practice would have led to a higher risk cohort of patients being prescribed COX-2 inhibitors rather than NSAIDs, thus reducing the apparent safety of COX-2 inhibitors in this study.

Additionally, during the study period both ulcer healing drugs and NSAIDs . . . [Full text of this article]

¹ Welshpool Medical Centre, Powys SY21 7ER Michael.Lewis@gp-w96010.wales.nhs.uk, ² Cheam Family Practice, Sutton, Surrey SM1 2HD

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

Julia Hippisley-Cox, Carol Coupland, and Richard Logan
BMJ 2005 331: 1310-1316. [Abstract] [Full Text] [PDF]

Efficacy and safety of COX 2 inhibitors

Roger Jones
BMJ 2002 325: 607-608. [Extract] [Full Text] [PDF]

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

Jonathan J Deeks, Lesley A Smith, and Matthew D Bradley
BMJ 2002 325: 619. [Abstract] [Full Text] [PDF]

Non-steroidal anti-inflammatory drugs and elderly patients

D N Bateman and J G Kennedy
BMJ 1995 310: 817-818. [Extract] [Full Text]

Are H₂ receptor antagonists safe over the counter drugs?

M Andersen and J S Schou
BMJ 1994 309: 493-494. [Extract] [Full Text]